http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9705133-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a32d67e6e11f1d08806fe121c9dfbd6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8b32bbe1f8c2e6f9f541fcf197840d6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06 |
| filingDate | 1996-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b379a0085f934676adf17c02075cd6c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae2665ef2504d325ee35da74bc644f1e |
| publicationDate | 1997-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9705133-A1 |
| titleOfInvention | Prodrugs of 4-[3-(trans-3-dimethylaminocyclobutyl)-1h-indol-5-yl-methyl]-4(s)oxazolidin-2-one, their preparation and their use as 5ht1-like receptor agonists |
| abstract | The present invention provides compounds of formula (I), wherein A is a C1-6alkyl, -O-C1-6alkyl, -O-phenyl or phenyl group and may optionally be substituted by one or more substituents selected from C1-3alkyl and halogen. These compounds act as prodrugs of 4-[3-(trans-5-dimethylaminocyclobutyl)-1H-indol-5-yl-methyl]-4(S)oxazolidin-2-one. The invention is also concerned with use of compounds of formula (I) in medicine, particularly as '5HT1-like' receptor agonists for prophylaxis and treatment of migraine, pharmaceutical compounds containing them and processes for their preparation. |
| priorityDate | 1995-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.